beta
IMUC
ImmunoCellular Therapeutics Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
Market Cap: 9.97 Million
Primary Exchange: NYSE American
Website: http://www.imuc.com
Shares Outstanding: 35.2 Million
Float: 34 Million
Dividend: 0.0 (0.0%)
Beta: 0.818087
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1383 trading days
From: 2013-08-06 To: 2018-10-16
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-11-21 | 40.0 | 1.0 | 40.0 |